Skip to main content

Table 1 Median (range) bronchoalveolar lavage fluid (BALF) and serum levels (pg/ml) of cytokines and adhesion molecules measured in the three groups of patients and controls

From: The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome

 

Group 1 (n = 23)

Group 2 (n = 14)

Group 3 (n = 28)

 

BALF

Serum

BALF

Serum

BALF

Serum

IL-1

267 (0–2030)

364 (3–908)

339 (0–630)

408 (160–556)

179 (0–860)

178 (3–563)

TNF-α

463 (0–2600)

204 (60–790)

210** (0–680)

383 (160–490)

145** (0–643)

254 (93–1280)

SICAM-1

970 (540–2460)

320 (66–1120)

1440 (460–2220)

365 (220–620)

1710 (260–4620)

255 (66–900)

sVCAM

350 (156–528)

355* (66–900)

416 (92–536)

330* (180–510)

330 (52–924)

150 (66–720)

  1. * P < 0.05 versus group 3; ** P < 0.0001 versus group 1. Comparisons were done using the Kruskal-Wallis test. IL-1 = interleukin-1; TNF-α = tumour necrosis factor-alpha; sICAM-1 = serumintercellular adhesion molecule-1; sVCAM = serum vascular adhesion molecule